September 29 - October 1, 2025
Sheraton, Boston, MA
Jeff leads the National Channel Account Team, as part of the US Market Access team. His team is responsible for Distributors, Retailers, Community & Acute GPOs, Dialysis organizations, Hospital IDN/Academic Systems and Community Contract Teams. Jeff’s role is focused on building strategic partnerships and developing portfolio/brand centric demand from distribution to the point of dispense for patients. Prior Experience Jeff’s career with AstraZeneca started in 2015. He has held roles in different parts of the organization to include Access Services, Managed Markets, and group purchasing organizations. Prior to AstraZeneca, Jeff began his professional career as a Certified Public Accountant with Deloitte, then came into Pharma with a career that has spanned over many roles including Sales, Sales Leadership, Training, Contract Operations, Payor, Distribution and Specialty/Retail Pharmacy with Lilly, Amgen, Dendreon and Cephalon. In his most recent position as Executive Director of National Channel Account Team, Jeff is accountable for our strategy to build partnerships with customers to address the demands of the new healthcare environment. His responsibilities included developing meaningful relationships with these customers and developing customer plans and approaches, bringing value to customers and the patients we serve. Education Jeff earned his Bachelor of Science in Strategic Management and Finance from University of California, Riverside and is a registered CPA.
In an era where remarkable advancements are revolutionizing patient care, the healthcare supply chain must evolve to meet the unique barriers these innovations bring. Featuring Ammie McAsey, SVP of Supply Chain Operations, McKesson, along with Jeff Davis, Executive Director of US Trade & Channel at AstraZeneca, and Dr. Leslie Busby, SVP & Chief Medical Officer, US Oncology Network, the panel discussion will delve into the interconnected roles of all stakeholders in shaping a future-ready supply chain. The session will tackle key obstacles such as the role of a modernized supply chain in mitigating drug shortages, scaling the supply chain to meet growing demands in larger patient populations, as well as explore opportunities to ensure efficient and secure delivery from manufacturer to patient.
• Identify how advanced therapies are challenging traditional supply chain models and what adaptations are required
• Explore cross-functional strategies to scale delivery infrastructure and reach growing patient populations
• Understand the importance of end-to-end visibility, real-time data, and collaboration in reducing disruption and ensuring continuity of care
Check out the incredible speaker line-up to see who will be joining Jeff.
Download The Latest Agenda